Results 191 to 200 of about 1,251,690 (298)
The misrepresentation of high drug costs: Who is looking out for the patient? [PDF]
Bachynsky JA, Tsuyuki RT.
europepmc +1 more source
Parallel 3D Bioprinting on SLIPS‐Microarrays
This work introduces the first truly parallel 3D bioprinting method, enabling both the simultaneous fabrication of hundreds of cell laden hydrogel 3D structures and their HTS in individual liquid compartments. By integrating Digital Light Processing (DLP) stereolithography with functional micropatterns, the platform decouples printing time from array ...
Julius von Padberg +3 more
wiley +1 more source
Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis. [PDF]
Kolhatkar A +6 more
europepmc +1 more source
Synthesis and characterization of light‐responsive donor–acceptor Stenhouse adducts (DASA)‐coated chlorhexidine‐loaded silica nanoparticles. Such a controllable drug‐delivery system enables the release of the antimicrobial drug on demand and in consecutive cycles, thereby maintaining the concentration within the therapeutic window.
Michèle Clerc +9 more
wiley +1 more source
Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? [PDF]
Mattingly TJ +4 more
europepmc +1 more source
Adaptive Hydrogels With Spatiotemporal Stiffening Using pH‐Modulating Enzymes
The chemomechanical coupling in an adaptive hydrogel is studied to further the development of adaptive hydrogels. This coupling is achieved by embedding a pH‐modulating enzyme in a pH‐responsive hydrogel. The enzymatic reaction can be triggered locally, which generates a pH‐decreasing wave throughout the system, increasing the crosslinking density and ...
Natascha Gray +3 more
wiley +1 more source
Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis. [PDF]
Levy JF, Rosenberg MA, Farrell PM.
europepmc +1 more source
ABSTRACT Electronic waste has emerged as a major environmental challenge, driven by the massive consumption and a limited lifetime of modern electronic devices, stimulating the development of sustainable electronics. Here, an all‐biomaterial gelatin‐choline‐citric acid ([Ch][CA]) ionogel is developed as an active binder to realize self‐sintered ...
Lin Guo +10 more
wiley +1 more source
Brand-name drug costs expected to rise under CETA. [PDF]
Sibbald B.
europepmc +1 more source

